Your Web Site
UPDATE - Forest Labs says Bystolic patent claims rejected (at Reuters)
yahoo.com 7 hrs agoBOSTON, Sept 4 (Reuters) - Forest Laboratories Inc (FRX.N: ) said on Thursday the U.S. Patent Office rejected all pending claims involving a patent covering the company's hypertension drug Bystolic, sending its shares down...

